VIGL stock results show that Vigil Neuroscience beat analyst estimates for earnings per share the second quarter of 2024. More
Articles
TRDA Stock Earnings: Entrada Therapeutics Beats EPS, Beats Revenue for Q2 2024
TRDA stock results show that Entrada Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
ACET Stock Earnings: Adicet Bio Beats EPS for Q2 2024
ACET stock results show that Adicet Bio beat analyst estimates for earnings per share the second quarter of 2024. More
IOBT Stock Earnings: IO Biotech Beats EPS for Q2 2024
IOBT stock results show that IO Biotech beat analyst estimates for earnings per share the second quarter of 2024. More
DC Stock Earnings: Dakota Gold Reported Results for Q2 2024
Dakota Gold just reported results for the second quarter of 2024. More
MURA Stock Earnings: Mural Oncology Beats EPS for Q2 2024
MURA stock results show that Mural Oncology beat analyst estimates for earnings per share the second quarter of 2024. More
XOMA Stock Earnings: XOMA Misses EPS, Beats Revenue for Q2 2024
XOMA stock results show that XOMA missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. More
